Home > Boards > US Listed > Medical - Healthcare > Biocept, Inc. (BIOC)

down big in after hours.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
ggm Member Profile
 
Followed By 7
Posts 197
Boards Moderated 0
Alias Born 03/18/13
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 5:21:58 PM
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations PR Newswire (US) - 2/14/2020 8:05:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2020 6:12:49 AM
Biocept Enters into Laboratory Services Agreement with California-Based Independent Physician Association PR Newswire (US) - 2/10/2020 8:05:00 AM
Biocept to Present at the 22nd Annual BIO CEO & Investor Conference PR Newswire (US) - 2/4/2020 8:05:00 AM
Biocept Announces Validation and Availability of its Liquid Biopsy Platform for the Detection of Actionable Cancer Biomarkers... PR Newswire (US) - 1/14/2020 8:05:00 AM
Biocept, Inc. Awarded United States Patent for the Use of Antibodies in Combination with Any Solid Surface to Detect Any Targ... PR Newswire (US) - 1/8/2020 9:00:00 AM
Biocept Announces Closing of $10.0 Million Underwritten Public Offering PR Newswire (US) - 12/12/2019 8:00:00 AM
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering PR Newswire (US) - 12/9/2019 9:15:00 AM
Biocept's Liquid Biopsy CTC Testing for Breast Cancer to Be Featured in Poster Presentation at the 2019 San Antonio Breast Ca... PR Newswire (US) - 12/3/2019 8:05:00 AM
Biocept Announces the Launch of its Liquid Biopsy Test to Detect TRK Biomarkers in the Blood of Patients Diagnosed with Cance... PR Newswire (US) - 11/21/2019 8:05:00 AM
Biocept Reports Third Quarter 2019 Financial Results PR Newswire (US) - 11/13/2019 4:05:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/8/2019 4:47:35 PM
Biocept Announces CE IVD Marks and Availability of its CEE-Sure® Blood Collection Tube and Sample Collection Shipping Kit in... PR Newswire (US) - 11/7/2019 8:05:00 AM
Biocept to Release Third Quarter 2019 Financial Results and Host Investor Conference Call on November 13, 2019 PR Newswire (US) - 11/6/2019 8:05:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 11/4/2019 6:06:00 AM
Biocept's Target Selector™ ctDNA Platform Demonstrates Single Copy Detection for EGFR, BRAF, and KRAS Mutations; Study Resu... PR Newswire (US) - 10/7/2019 8:05:00 AM
Biocept Announces Issuance of South Korean Patent Covering its Target Selector™ Oncogene Mutation Enrichment and Detection ... PR Newswire (US) - 10/3/2019 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2019 4:16:09 PM
Biocept to Present at Two Investment Conferences in September PR Newswire (US) - 9/3/2019 8:05:00 AM
High Sensitivity of Biocept's Target Selector™ Platform Using CEE-Sure™ Blood Collection Tubes to Be Featured in Poster P... PR Newswire (US) - 8/22/2019 8:05:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/15/2019 6:19:34 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 9:24:19 AM
Biocept Receives Three Additional Patents Covering its Antibody and Microchannel Technology and Enhanced Detection of Cancer ... PR Newswire (US) - 8/13/2019 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2019 4:21:50 PM
ggm   Monday, 03/09/15 05:21:04 PM
Re: cazual post# 715
Post # of 2317 
down big in after hours.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist